A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RD01 (Pegerythropoietin) in Healthy Chinese Volunteers

NCT03657238 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: RD01
DRUG: Placebo

Sponsor

Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd